Page last updated: 2024-11-08

rhinacanthone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

rhinacanthone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID196964
CHEMBL ID512946
MeSH IDM0379560

Synonyms (6)

Synonym
rhinacanthone
CHEMBL512946
3,3-dimethyl-2,4-dihydrobenzo[h]chromene-5,6-dione
3,4-dihydro-3,3-dimethyl-2h-naphtho(1,2-b)pyran-5,6-dione
171522-36-4
DTXSID60169127

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Rhinacanthone-treated HeLa cells displayed several apoptotic features as evidenced by the appearance of chromatin condensation, internucleosomal DNA fragmentation, increase in the proportion of sub G(1) apoptotic cells, and externalization of annexin-V."( Induction of apoptosis by rhinacanthone isolated from Rhinacanthus nasutus roots in human cervical carcinoma cells.
Hahnvajanawong, C; Kanokmedhakul, K; Kongkathip, N; Oku, N; Piyaviriyakul, S; Ruchirawat, S; Siripong, P; Yahuafai, J, 2009
)
1.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1849773Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2021European journal of medicinal chemistry, Jan-15, Volume: 210A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials.
AID1849774Cytotoxicity against human HepG2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2021European journal of medicinal chemistry, Jan-15, Volume: 210A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials.
AID1849775Cytotoxicity against human KB cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2021European journal of medicinal chemistry, Jan-15, Volume: 210A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.04 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]